EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study

Elisa Barbieri iD, Yuxi Wang iD, Anna Cantarutti iD, Antonio Scamarcia iD, Luigi Cantarutti, Giovanni Corrao iD, Aleksandra Torbica, Carlo Giaquinto

Vaccines · 28.09.2024 · 12 (10) · 1113

DOI: 10.3390/vaccines12101113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 28.09.2024. Verfasst von Elisa Barbieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Women's and Children's Health, University of Padua, 35100 Padua, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of the Education, University and Research, European Union - Next Generation EU under the National Recovery and Resilience Plan (NRRP), European Union—Next Generation EU under the National Recovery and Resilience Plan (NRRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Seasonal influenza annually puts a significant burden on the pediatric population, especially the youngest, causing severe illness and death. Additionally, associated healthcare costs cause a significant financial strain on healthcare systems. While vaccination is the most effective prevention method, its cost-effectiveness for healthy children remains unassessed.

Methods

Using the Pedianet database spanning from 2009 to 2019, we analyzed influenza cases among 6-month-olds to 14-year-olds in Italy. Data included influenza-related medical visits, prescriptions, exams, emergency visits, hospitalizations, and costs. Adverse events and quality-adjusted life years (QALYs) were considered from the existing literature. A static decision-tree model compared annual vaccination strategies, assessing probabilities for influenza or influenza-like illnesses by vaccination status. Incremental cost-effectiveness ratios (ICERs) were calculated, along with sensitivity analyses and cost-effectiveness acceptability curve generation.

Results

Mean total influenza costs for vaccinated children averaged EUR 18.6 (range 0–3175.9, including EUR 15.79 for the influenza vaccination), whereas costs for unvaccinated children were consistently lower at around EUR 4.6 (range 0–3250.1). The average ICER for years where vaccine and virus strains are matched was EUR 29,831 per QALY, which is below the EUR 40,000 threshold set by the Italian National Health Services. The ICER values range from EUR 13,736 (2017/2018) to EUR 72,153 (2013/2014). Averted influenza costs averaged EUR 23 per case, with fluctuations over the years. In most observed years, influenza vaccination was cost-effective from the healthcare providers’ standpoint. The exception was 2009–2010, due to a mismatch between vaccine and virus strains.

Conclusions

This study highlights the economic viability of influenza vaccination, especially when virus and vaccine strains align. It demonstrates the potential of vaccination programs in preserving children’s health and well-being while managing healthcare costs.

Schlagwörter

Stichwörter der Autor:innen

Italychildrencost-effectivenessinfluenza vaccination

Autor:innen und Institutionen

  • Division of Pediatric Infectious Diseases, Department of Women's and Children's Health, University of Padua, 35100 Padua, Italy.
  • Centre for Research on Health and Social Care Management, Bocconi University, 20136 Milan, Italy.
  • Institut National D'études Démographiques, 75980 Paris, France.
  • Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.
  • National Centre for Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.
  • Società Servizi Telematici-Pedianet, 35100 Padua, Italy.

ORCID-Profile: Elisa Barbieri, Yuxi Wang, Anna Cantarutti, Antonio Scamarcia, Giovanni Corrao

Förderung

  • Italian Ministry of the Education, University and Research
  • European Union - Next Generation EU under the National Recovery and Resilience Plan (NRRP)
  • European Union—Next Generation EU under the National Recovery and Resilience Plan (NRRP)

Zitieren

APA

Barbieri, E., Wang, Y., Cantarutti, A., Scamarcia, A., Cantarutti, L., Corrao, G., Torbica, A., & Giaquinto, C. (2024). Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study. Vaccines, 12(10), 1113. https://doi.org/10.3390/vaccines12101113

Vancouver

Barbieri E, Wang Y, Cantarutti A, Scamarcia A, Cantarutti L, Corrao G, et al. Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study. Vaccines. 2024;12(10):1113. doi:10.3390/vaccines12101113

BibTeX
@article{Barbieri2024,
  author = {Barbieri, Elisa and Wang, Yuxi and Cantarutti, Anna and Scamarcia, Antonio and Cantarutti, Luigi and Corrao, Giovanni and Torbica, Aleksandra and Giaquinto, Carlo},
  title = {Cost-Effectiveness of Influenza Vaccination in Healthy Children: A 10-Year Population-Based Study},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {10},
  pages = {1113},
  doi = {10.3390/vaccines12101113}
}
Kostenlos starten →